The application of NF-κB antagonists can significantly reduce epidermal thickness, acanthosis, and inflammatory symptoms in psoriasis-like mice [8].Activation of the NF-κB signaling pathway induces the expression of pro-inflammatory factors such as NO, IL-1β, IL-6, and COX-2 [65]. Here, NFKB1 is linked to psoriasis.